RUS MED Exports Pvt. Ltd.
Indian Pharmaceutical Exporter ยท Advanced Oncology Specialist ยท $483.6K Total Trade ยท DGFT Verified
RUS MED Exports Pvt. Ltd. is an Indian pharmaceutical exporter with a total trade value of $483.6K across 4 products in 2 therapeutic categories. Based on 29 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Cytarabine ($311.9K), Pemetrexed ($88.3K), Etoposide ($48.0K).
RUS MED Exports Pvt. Ltd. โ Export Portfolio & Destination Treemap

Who is RUS MED Exports Pvt. Ltd.? โ Company Overview & Market Position
RUS MED Exports Pvt. Ltd. is an Indian pharmaceutical exporter established in 2004, headquartered in Mumbai, Maharashtra. The company is privately held, with a Corporate Identification Number (CIN) of U51509MH2004PTC146939. Its registered office is located at A-503/504, Remi Bizcourt, Shah Industrial Estate, Off Veera Desai Road, Andheri (W), Mumbai-400053. The company specializes in exporting high-quality oncology generic medicines, primarily targeting markets in Russia and the Commonwealth of Independent States (CIS).
As of the latest available data, RUS MED Exports Pvt. Ltd. has a total export value of $484,000 USD, with 29 shipments across four products in two therapeutic categories. The company's top five products include Cytarabine ($312,000), Pemetrexed ($88,000), Etoposide ($48,000), and Dacarbazine ($35,000). The primary therapeutic focus is on advanced oncology, accounting for 90.1% of the portfolio, with oncology comprising the remaining 9.9%. The company's product portfolio is highly concentrated, with the top five products representing 100% of its exports.